Literature DB >> 7271447

Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese.

G S Shukla, S V Chandra.   

Abstract

The turnover rate of striatal dopamine (DA) and the effect of L-dopa treatment was investigated in rats after the daily oral administration of MnCl2 . 4H20 for a period of 30 days. The turnover rate of striatal DA, as determined by the administration of alpha-methyl-p-tyrosine, increased significantly in manganese-exposed rats. L-Dopa administration resulted in a significant elevation in the levels of DA and its metabolite, homovanillic acid, in manganese-exposed rats, but these neurochemical changes could not be correlated with the concentration of manganese in the striatum. We therefore advise the L-dopa therapy should not be tried in early manganese intoxication, as it may aggravate manic symptoms due to marked increase in brain DA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271447     DOI: 10.1007/BF00368679

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.

Authors:  S Bariletto; E Dollar; F Leitz
Journal:  J Neurochem       Date:  1975-08       Impact factor: 5.372

2.  BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE.

Authors:  S SPECTOR; A SJOERDSMA; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1965-01       Impact factor: 4.030

3.  Interrelation of intestinal transport system for manganese and iron.

Authors:  A B Thomson; D Olatunbosun; L S Valverg
Journal:  J Lab Clin Med       Date:  1971-10

4.  Locomotor activity and regional brain noradrenaline levels in rats treated with prenylamine.

Authors:  S T Broitman; A O Donoso
Journal:  Experientia       Date:  1971

5.  Chronic manganese poisoning. Individual susceptibility and absorption of iron.

Authors:  I Mena; K Horiuchi; K Burke; G C Cotzias
Journal:  Neurology       Date:  1969-10       Impact factor: 9.910

6.  Levels of 5-hydroxytryptamine, dopamine and norepinephrine in whole brain of rabbits in chronic manganese toxicity.

Authors:  S J Mustafa; S V Chandra
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

7.  Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.

Authors:  J Hyttel
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

8.  Some characteristics of brain tyrosine hydroxylase.

Authors:  E G McGeer; S Gibson; P L McGeer
Journal:  Can J Biochem       Date:  1967-10

9.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

10.  Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine.

Authors:  C Sadavongvivad
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

View more
  4 in total

1.  Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water.

Authors:  Saritha Krishna; Celia A Dodd; Shahryar K Hekmatyar; Nikolay M Filipov
Journal:  Arch Toxicol       Date:  2013-07-06       Impact factor: 5.153

2.  Concurrent exposure to lead, manganese, and cadmium and their distribution to various brain regions, liver, kidney, and testis of growing rats.

Authors:  G S Shukla; S V Chandra
Journal:  Arch Environ Contam Toxicol       Date:  1987-05       Impact factor: 2.804

3.  Urinary excretion of homovanillic acid in workers exposed to manganese.

Authors:  J P Buchet; C Magos; H Roels; E Ceulemans; R Lauwerys
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Effect of latent iron deficiency on metal levels of rat brain regions.

Authors:  A Shukla; K N Agarwal; G S Shukla
Journal:  Biol Trace Elem Res       Date:  1989-11       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.